ADVERTISEMENT
13th Biennial IAGS Meeting: Participant Disclosures
Participant Disclosures
It is the policy of the Royal New Zealand College of General Practitioners (RNZCGP) to insure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs.
All speakers, chairpersons, panelists and planning committee members participating in this program are expected to disclose to the program audience all potential conflicts of interest that might introduce a bias in their presentations.
The intent of this policy is not to prevent a participant with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the participant’s outside interests may reflect a possible bias in either the exposition or the conclusions presented. The participants listed below have disclosed if they have any existing potential conflicts of interest with respect to their participation in our program:
James Adams
Honoraria: Boston Heart Diagnostic Laboratories; Cardio Dx, Inc.; Kowa Pharmaceuticals
H. Vernon “Skip” Anderson
No Potential Conflict of Interest to Report
Steven Bailey
Grant / Research Support: Edwards LifeSciences
Consulting Fees / Honoraria: Edwards LifeSciences
Intellectual Property Rights: UTHSCSA
Other Financial Benefit: CCI Editor in Chief
Evelyn Baram‐Clothier
No Potential Conflict of Interest to Report
David Baron
No Potential Conflict of Interest to Report
Robert Bersin
Advisory Board: Boston Scientific; MedAlliance; Transverse Medical
Consulting Relationship: Abbott Vascular; Boston Scientific; Cardiovascular Systems Inc.; Cook Medical, Inc.; Cordis Endovascular; Medtronic Vascular; Spectranetics Corp; St. Jude Medical; W.L. Gore
Equity Interest: Ablative Solutions; Boston Scientific; Cordis Endovascular; MedAlliance; Omeros Corp; QT Vascular; Transverse Medical; Vatrix Medical
Proctor or Training Course Sponsorships: Abbott Vascular; Cook Medical, Inc.; Medtronic Vascular; W.L. Gore
Speakers Bureau: Abbott Vascular; Boston Scientific
Stock Options or Positions: Transverse Medical
Rafael Beyar
Founder & Stockholder: Corindus Vascular Robotics
Seth Bilazarian
Employed: Abiomed, Inc.
John Brumleve
Employed: Cook Medical (Director, Business Development)
Douglas Cavaye
No Potential Conflict of Interest to Report
Michael Cowley
No Potential Conflict of Interest to Report
Larry Dean
Grants: Edwards LifeSciences
Ronald Dick
Advisory Committee: AstraZeneca
Consulting: Abbott Vascular
Germano DiSciascio
No Potential Conflict of Interest to Report
Simon Dixon
No Potential Conflict of Interest to Report
Tony Dortimer
No Potential Conflict of Interest to Report
Tim Fischell
Advisory Committee: Abbott Vascular; Trireme
Consulting: Trireme; AngelMed
Honoraria: Abbott Vascular
Royalties: Cordis; Svelte, Inc.
Commercial Interest: Ablative Solutions (Peregrine)
Employed: Ablative Solutions
Stockholder / Investments: Ablative Solutions
Teaching Honoraria: Abbott Vascular; AstraZeneca
Lillian Garcia Palmer
Employed: Abiomed, Inc.
Adam Greenbaum
Advisory Committee: Transmural Systems, Inc.
Research Contract: St. Jude Medical
Honoraria: Abiomed; Edwards LifeSciences; St. Jude Medical
Equity: Transmural Systems, Inc.
Laurie Gustafson
No Potential Conflict of Interest to Report
Tarek Helmy
No Potential Conflict of Interest to Report
Tim Henry
No Potential Conflict of Interest to Report
Jay Hollman
No Potential Conflict of Interest to Report
Jamey Jacobs
Employed: Abbott Vascular
Lloyd Jones
Employed: Boston Scientific
Nickolas Kipshidze
No Potential Conflict of Interest to Report
J. Jeffrey
Marshall Consulting: Abbott Vascular; Boston Scientific; Medtronic
Research Contract: Abbott Vascular; Boston Scientific; The Medicines Company; Medtronic; Sanofi; St. Jude Medical
Patrick McCoy
Employed: Boston Scientific
Stockholder: Boston Scientific
Madhav Menon
No Potential Conflict of Interest to Report
Ian Meredith
Advisory Committee: Boston Scientific; Medtronic; TWELVE
Consulting: Boston Scientific; Medtronic; TWELVE
Honoraria: Boston Scientific International
Proctor: Lotus Valve
Sundeep Mishra
No Potential Conflict of Interest to Report
Michael Mooney
No Potential Conflict of Interest to Report
Max Muhs
No Potential Conflict of Interest to Report
Brian O’Murchu
No Potential Conflict of Interest to Report
Brian O’Neill
Consulting: Cardiac Assist
Research Contract: Edwards LifeSciences
William O’Neill
Consulting: Edwards LifeSciences; Medtronic; St. Jude Medical
Stockholder / Investments: Neovasc, Inc.
Paul Overlie
No Potential Conflict of Interest to Report
Augusto Pichard
Consulting (Proctor): Boston Scientific; Edwards LifeSciences; Medtronic; St. Jude Medical
Paul Puccioni
Employed: The Medicines Company
Aniket Puri
No Potential Conflict of Interest to Report
Renato Ramos
No Potential Conflict of Interest to Report
Alfredo Rodriguez
No Potential Conflict of Interest to Report
Gary Roubin
Royalties: Cook, Inc.
Commercial Interest: Essential Medical, Inc. (Manta)
Paula Rowbury
No Potential Conflict of Interest to Report
Marcia Schallehn
Consulting: Accreditation for Cardiovascular Excellence
Fayaz Shawl
No Potential Conflict of Interest to Report
Jason Struck
Employed: Boston Scientific
Marco Wainstein
Advisory Committee: Abbott Vascular
Consulting: Biotronik
Honoraria: AstraZeneca
Bonnie Weiner
No Potential Conflict of Interest to Report
Hall Whitworth
No Potential Conflict of Interest to Report
Gerard Wilkins
Grants: Boston Scientific; St. Jude Medical; Biosensors
Michael Williams
Advisory Committee: AstraZeneca – PEGASUS Advisory Board
Research Contract: AstraZeneca; Eisai; Janssen Pharmaceuticals; Johnson & Johnson
David Wood
Consulting: Edwards LifeSciences; Medtronic; St. Jude Medical
Research Contract: AstraZeneca; Boston Scientific; Edwards LifeSciences
Ben Yerbury
Employed: Boston Scientific
